Selected research
Market Analysis & Forecast
Global Pet Genetic Screening Platform Market Analysis and Forecast 2026-2032
Market perspective
The global Pet Genetic Screening Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pet Genetic Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pet Genetic Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pet Genetic Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pet Genetic Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pet Genetic Screening Platform include Wisdom Panel, Embark Veterinary, Basepaws, Orivet Genetic Pet Care, Paw Print Genetics, Animal Genetics, VetGen, Antagene and Laboklin, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pet Genetic Screening Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pet Genetic Screening Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Pet Genetic Screening Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Genetic Screening Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Genetic Screening Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pet Genetic Screening Platform revenue, projected growth trends, production technology, application and end-user industry.
Pet Genetic Screening Platform Segment by Company
Wisdom Panel
Embark Veterinary
Basepaws
Orivet Genetic Pet Care
Paw Print Genetics
Animal Genetics
VetGen
Antagene
Laboklin
UC Davis
OptiGen
VHLGenetics
Sinogene
PawKnows
Circle Dog
BGI Genomics
GENEWIZ
Pet Genetic Screening Platform Segment by Type
Single Gene Defect Screening Platform
Whole Genome Health Risk Screening Platform
Pet Genetic Screening Platform Segment by Application
Medical Institutions
Pet Breeding Companies
Others
Pet Genetic Screening Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Genetic Screening Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Genetic Screening Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Genetic Screening Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pet Genetic Screening Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pet Genetic Screening Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Genetic Screening Platform revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Gene Defect Screening Platform
- Whole Genome Health Risk Screening Platform
Applications
- Medical Institutions
- Pet Breeding Companies
- Others
Companies covered
- Wisdom Panel
- Embark Veterinary
- Basepaws
- Orivet Genetic Pet Care
- Paw Print Genetics
- Animal Genetics
- VetGen
- Antagene
- Laboklin
- UC Davis
- OptiGen
- VHLGenetics
- Sinogene
- PawKnows
- Circle Dog
- BGI Genomics
- GENEWIZ
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pet Genetic Screening Platform Market by Type
- 1.2.1 Global Pet Genetic Screening Platform Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Single Gene Defect Screening Platform
- 1.2.3 Whole Genome Health Risk Screening Platform
- 1.3 Pet Genetic Screening Platform Market by Application
- 1.3.1 Global Pet Genetic Screening Platform Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical Institutions
- 1.3.3 Pet Breeding Companies
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pet Genetic Screening Platform Market Dynamics
- 2.1 Pet Genetic Screening Platform Industry Trends
- 2.2 Pet Genetic Screening Platform Industry Drivers
- 2.3 Pet Genetic Screening Platform Industry Opportunities and Challenges
- 2.4 Pet Genetic Screening Platform Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pet Genetic Screening Platform Market Perspective (2021-2032)
- 3.2 Global Pet Genetic Screening Platform Growth Trends by Region
- 3.2.1 Global Pet Genetic Screening Platform Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pet Genetic Screening Platform Market Size by Region (2021-2026)
- 3.2.3 Global Pet Genetic Screening Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pet Genetic Screening Platform Revenue by Players
- 4.1.1 Global Pet Genetic Screening Platform Revenue by Players (2021-2026)
- 4.1.2 Global Pet Genetic Screening Platform Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pet Genetic Screening Platform Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pet Genetic Screening Platform Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pet Genetic Screening Platform Key Players Headquarters & Area Served
- 4.4 Global Pet Genetic Screening Platform Players, Product Type & Application
- 4.5 Global Pet Genetic Screening Platform Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pet Genetic Screening Platform Market CR5 and HHI
- 4.6.3 2025 Pet Genetic Screening Platform Tier 1, Tier 2, and Tier 3
5 Pet Genetic Screening Platform Market Size by Type
- 5.1 Global Pet Genetic Screening Platform Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pet Genetic Screening Platform Revenue by Type (2021-2032)
- 5.3 Global Pet Genetic Screening Platform Revenue Market Share by Type (2021-2032)
6 Pet Genetic Screening Platform Market Size by Application
- 6.1 Global Pet Genetic Screening Platform Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pet Genetic Screening Platform Revenue by Application (2021-2032)
- 6.3 Global Pet Genetic Screening Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Wisdom Panel
- 7.1.1 Wisdom Panel Company Information
- 7.1.2 Wisdom Panel Business Overview
- 7.1.3 Wisdom Panel Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.1.4 Wisdom Panel Pet Genetic Screening Platform Product Portfolio
- 7.1.5 Wisdom Panel Recent Developments
- 7.2 Embark Veterinary
- 7.2.1 Embark Veterinary Company Information
- 7.2.2 Embark Veterinary Business Overview
- 7.2.3 Embark Veterinary Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.2.4 Embark Veterinary Pet Genetic Screening Platform Product Portfolio
- 7.2.5 Embark Veterinary Recent Developments
- 7.3 Basepaws
- 7.3.1 Basepaws Company Information
- 7.3.2 Basepaws Business Overview
- 7.3.3 Basepaws Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.3.4 Basepaws Pet Genetic Screening Platform Product Portfolio
- 7.3.5 Basepaws Recent Developments
- 7.4 Orivet Genetic Pet Care
- 7.4.1 Orivet Genetic Pet Care Company Information
- 7.4.2 Orivet Genetic Pet Care Business Overview
- 7.4.3 Orivet Genetic Pet Care Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.4.4 Orivet Genetic Pet Care Pet Genetic Screening Platform Product Portfolio
- 7.4.5 Orivet Genetic Pet Care Recent Developments
- 7.5 Paw Print Genetics
- 7.5.1 Paw Print Genetics Company Information
- 7.5.2 Paw Print Genetics Business Overview
- 7.5.3 Paw Print Genetics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.5.4 Paw Print Genetics Pet Genetic Screening Platform Product Portfolio
- 7.5.5 Paw Print Genetics Recent Developments
- 7.6 Animal Genetics
- 7.6.1 Animal Genetics Company Information
- 7.6.2 Animal Genetics Business Overview
- 7.6.3 Animal Genetics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.6.4 Animal Genetics Pet Genetic Screening Platform Product Portfolio
- 7.6.5 Animal Genetics Recent Developments
- 7.7 VetGen
- 7.7.1 VetGen Company Information
- 7.7.2 VetGen Business Overview
- 7.7.3 VetGen Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.7.4 VetGen Pet Genetic Screening Platform Product Portfolio
- 7.7.5 VetGen Recent Developments
- 7.8 Antagene
- 7.8.1 Antagene Company Information
- 7.8.2 Antagene Business Overview
- 7.8.3 Antagene Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.8.4 Antagene Pet Genetic Screening Platform Product Portfolio
- 7.8.5 Antagene Recent Developments
- 7.9 Laboklin
- 7.9.1 Laboklin Company Information
- 7.9.2 Laboklin Business Overview
- 7.9.3 Laboklin Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.9.4 Laboklin Pet Genetic Screening Platform Product Portfolio
- 7.9.5 Laboklin Recent Developments
- 7.10 UC Davis
- 7.10.1 UC Davis Company Information
- 7.10.2 UC Davis Business Overview
- 7.10.3 UC Davis Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.10.4 UC Davis Pet Genetic Screening Platform Product Portfolio
- 7.10.5 UC Davis Recent Developments
- 7.11 OptiGen
- 7.11.1 OptiGen Company Information
- 7.11.2 OptiGen Business Overview
- 7.11.3 OptiGen Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.11.4 OptiGen Pet Genetic Screening Platform Product Portfolio
- 7.11.5 OptiGen Recent Developments
- 7.12 VHLGenetics
- 7.12.1 VHLGenetics Company Information
- 7.12.2 VHLGenetics Business Overview
- 7.12.3 VHLGenetics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.12.4 VHLGenetics Pet Genetic Screening Platform Product Portfolio
- 7.12.5 VHLGenetics Recent Developments
- 7.13 Sinogene
- 7.13.1 Sinogene Company Information
- 7.13.2 Sinogene Business Overview
- 7.13.3 Sinogene Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.13.4 Sinogene Pet Genetic Screening Platform Product Portfolio
- 7.13.5 Sinogene Recent Developments
- 7.14 PawKnows
- 7.14.1 PawKnows Company Information
- 7.14.2 PawKnows Business Overview
- 7.14.3 PawKnows Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.14.4 PawKnows Pet Genetic Screening Platform Product Portfolio
- 7.14.5 PawKnows Recent Developments
- 7.15 Circle Dog
- 7.15.1 Circle Dog Company Information
- 7.15.2 Circle Dog Business Overview
- 7.15.3 Circle Dog Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.15.4 Circle Dog Pet Genetic Screening Platform Product Portfolio
- 7.15.5 Circle Dog Recent Developments
- 7.16 BGI Genomics
- 7.16.1 BGI Genomics Company Information
- 7.16.2 BGI Genomics Business Overview
- 7.16.3 BGI Genomics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.16.4 BGI Genomics Pet Genetic Screening Platform Product Portfolio
- 7.16.5 BGI Genomics Recent Developments
- 7.17 GENEWIZ
- 7.17.1 GENEWIZ Company Information
- 7.17.2 GENEWIZ Business Overview
- 7.17.3 GENEWIZ Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
- 7.17.4 GENEWIZ Pet Genetic Screening Platform Product Portfolio
- 7.17.5 GENEWIZ Recent Developments
8 North America
- 8.1 North America Pet Genetic Screening Platform Revenue (2021-2032)
- 8.2 North America Pet Genetic Screening Platform Revenue by Type (2021-2032)
- 8.2.1 North America Pet Genetic Screening Platform Revenue by Type (2021-2026)
- 8.2.2 North America Pet Genetic Screening Platform Revenue by Type (2027-2032)
- 8.3 North America Pet Genetic Screening Platform Revenue Share by Type (2021-2032)
- 8.4 North America Pet Genetic Screening Platform Revenue by Application (2021-2032)
- 8.4.1 North America Pet Genetic Screening Platform Revenue by Application (2021-2026)
- 8.4.2 North America Pet Genetic Screening Platform Revenue by Application (2027-2032)
- 8.5 North America Pet Genetic Screening Platform Revenue Share by Application (2021-2032)
- 8.6 North America Pet Genetic Screening Platform Revenue by Country
- 8.6.1 North America Pet Genetic Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pet Genetic Screening Platform Revenue by Country (2021-2026)
- 8.6.3 North America Pet Genetic Screening Platform Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pet Genetic Screening Platform Revenue (2021-2032)
- 9.2 Europe Pet Genetic Screening Platform Revenue by Type (2021-2032)
- 9.2.1 Europe Pet Genetic Screening Platform Revenue by Type (2021-2026)
- 9.2.2 Europe Pet Genetic Screening Platform Revenue by Type (2027-2032)
- 9.3 Europe Pet Genetic Screening Platform Revenue Share by Type (2021-2032)
- 9.4 Europe Pet Genetic Screening Platform Revenue by Application (2021-2032)
- 9.4.1 Europe Pet Genetic Screening Platform Revenue by Application (2021-2026)
- 9.4.2 Europe Pet Genetic Screening Platform Revenue by Application (2027-2032)
- 9.5 Europe Pet Genetic Screening Platform Revenue Share by Application (2021-2032)
- 9.6 Europe Pet Genetic Screening Platform Revenue by Country
- 9.6.1 Europe Pet Genetic Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pet Genetic Screening Platform Revenue by Country (2021-2026)
- 9.6.3 Europe Pet Genetic Screening Platform Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pet Genetic Screening Platform Revenue (2021-2032)
- 10.2 China Pet Genetic Screening Platform Revenue by Type (2021-2032)
- 10.2.1 China Pet Genetic Screening Platform Revenue by Type (2021-2026)
- 10.2.2 China Pet Genetic Screening Platform Revenue by Type (2027-2032)
- 10.3 China Pet Genetic Screening Platform Revenue Share by Type (2021-2032)
- 10.4 China Pet Genetic Screening Platform Revenue by Application (2021-2032)
- 10.4.1 China Pet Genetic Screening Platform Revenue by Application (2021-2026)
- 10.4.2 China Pet Genetic Screening Platform Revenue by Application (2027-2032)
- 10.5 China Pet Genetic Screening Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pet Genetic Screening Platform Revenue (2021-2032)
- 11.2 Asia Pet Genetic Screening Platform Revenue by Type (2021-2032)
- 11.2.1 Asia Pet Genetic Screening Platform Revenue by Type (2021-2026)
- 11.2.2 Asia Pet Genetic Screening Platform Revenue by Type (2027-2032)
- 11.3 Asia Pet Genetic Screening Platform Revenue Share by Type (2021-2032)
- 11.4 Asia Pet Genetic Screening Platform Revenue by Application (2021-2032)
- 11.4.1 Asia Pet Genetic Screening Platform Revenue by Application (2021-2026)
- 11.4.2 Asia Pet Genetic Screening Platform Revenue by Application (2027-2032)
- 11.5 Asia Pet Genetic Screening Platform Revenue Share by Application (2021-2032)
- 11.6 Asia Pet Genetic Screening Platform Revenue by Country
- 11.6.1 Asia Pet Genetic Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pet Genetic Screening Platform Revenue by Country (2021-2026)
- 11.6.3 Asia Pet Genetic Screening Platform Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pet Genetic Screening Platform Revenue (2021-2032)
- 12.2 SAMEA Pet Genetic Screening Platform Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pet Genetic Screening Platform Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pet Genetic Screening Platform Revenue by Type (2027-2032)
- 12.3 SAMEA Pet Genetic Screening Platform Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pet Genetic Screening Platform Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pet Genetic Screening Platform Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pet Genetic Screening Platform Revenue by Application (2027-2032)
- 12.5 SAMEA Pet Genetic Screening Platform Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pet Genetic Screening Platform Revenue by Country
- 12.6.1 SAMEA Pet Genetic Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pet Genetic Screening Platform Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pet Genetic Screening Platform Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst